Norbert Frey Selected Research

Critical Illness (Critically Ill)

12/2020	Longitudinal Multi-omics Analyses Identify Responses of Megakaryocytes, Erythroid Cells, and Plasmablasts as Hallmarks of Severe COVID-19.
1/2018	Elevated serum levels of bone sialoprotein during ICU treatment predict long-term mortality in critically ill patients.
1/2018	Serum levels of kisspeptin are elevated in critically ill patients.
1/2016	Elevated Omentin Serum Levels Predict Long-Term Survival in Critically Ill Patients.
1/2016	Serum Levels of TNF Receptor Ligands Are Dysregulated in Sepsis and Predict Mortality in Critically Ill Patients.
6/2015	Persistently elevated osteopontin serum levels predict mortality in critically ill patients.
1/2015	Authors' response: impact of renal replacement therapy on osteopontin levels in critically ill patients.
1/2013	Circulating microRNA-150 serum levels predict survival in patients with critical illness and sepsis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Norbert Frey Research Topics

Disease

47	Heart Failure 04/2024 - 01/2002
27	Cardiomyopathies (Cardiomyopathy) 04/2024 - 12/2004
24	Hypertrophy 01/2023 - 01/2002
23	Myocardial Infarction 01/2024 - 10/2002
21	Aortic Valve Stenosis (Aortic Stenosis) 04/2024 - 09/2015
15	Cardiomegaly (Heart Hypertrophy) 01/2023 - 01/2002
14	Atrial Fibrillation 01/2024 - 01/2017
13	Inflammation (Inflammations) 03/2024 - 08/2013
11	Cardiovascular Diseases (Cardiovascular Disease) 03/2024 - 11/2009
10	Fibrosis (Cirrhosis) 01/2024 - 10/2011
10	Stroke (Strokes) 10/2023 - 07/2010
9	Neoplasms (Cancer) 11/2023 - 12/2018
9	Hemorrhage 10/2023 - 02/2015
8	Heart Diseases (Heart Disease) 02/2024 - 12/2007
8	Coronary Artery Disease (Coronary Atherosclerosis) 02/2023 - 04/2007
8	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 01/2023 - 05/2008
8	Critical Illness (Critically Ill) 12/2020 - 01/2013
7	Infarction (Infarctions) 11/2022 - 01/2008
6	Acute Coronary Syndrome 01/2024 - 02/2018
6	Amyloidosis 12/2023 - 09/2014
6	ST Elevation Myocardial Infarction 10/2023 - 10/2002
6	Myocarditis (Carditis) 06/2023 - 12/2018
6	Acute Kidney Injury (Acute Renal Failure) 01/2022 - 02/2018
5	Cardiogenic Shock 10/2023 - 07/2010
5	Sepsis (Septicemia) 01/2018 - 09/2013
4	Hypertension (High Blood Pressure) 03/2024 - 01/2020
4	Immunoglobulin Light-chain Amyloidosis 01/2023 - 09/2014
4	Chronic Renal Insufficiency 01/2023 - 01/2021
4	Takotsubo Cardiomyopathy 03/2022 - 04/2007
3	Cardiotoxicity 03/2024 - 04/2023
3	Bundle-Branch Block (Fascicular Block) 01/2024 - 10/2021
3	Cardiac Arrhythmias (Arrythmia) 09/2023 - 01/2016
3	Schizophrenia (Dementia Praecox) 01/2023 - 11/2013
3	Pulmonary Hypertension 01/2022 - 03/2012
3	Infections 12/2021 - 10/2020
3	Left Ventricular Dysfunction 03/2021 - 04/2007
3	Necrosis 01/2021 - 11/2009
3	COVID-19 12/2020 - 01/2020
3	Hypoxia (Hypoxemia) 01/2020 - 07/2011
3	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 01/2019 - 05/2012
2	Marfan Syndrome (Marfan's Syndrome) 03/2024 - 11/2021
2	Muscular Dystrophies (Muscular Dystrophy) 01/2024 - 06/2006
2	Insulin Resistance 12/2023 - 01/2020
2	Rupture 12/2023 - 01/2016
2	Thrombosis (Thrombus) 10/2023 - 01/2016
2	Frailty 10/2023 - 01/2021
2	Diabetes Mellitus 08/2023 - 07/2022

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 03/2024 - 04/2002
21	Biomarkers (Surrogate Marker)IBA 03/2024 - 04/2007
13	Troponin T (Troponin T1)IBA 02/2024 - 10/2002
12	CalcineurinIBA 01/2023 - 04/2002
8	pro-brain natriuretic peptide (1-76)IBA 02/2024 - 09/2014
8	OsteopontinIBA 01/2017 - 12/2007
7	TroponinIBA 01/2024 - 01/2017
7	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2013
6	CytokinesIBA 03/2024 - 11/2009
6	omega-Chloroacetophenone (Mace)IBA 01/2024 - 01/2019
5	Amyloid (Amyloid Fibrils)IBA 04/2024 - 01/2018
5	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2023 - 01/2020
4	Phosphotransferases (Kinase)IBA 04/2024 - 07/2014
4	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2016
4	GadoliniumIBA 01/2024 - 09/2015
4	Insulin (Novolin)FDA Link 12/2023 - 01/2016
4	Immune Checkpoint InhibitorsIBA 03/2023 - 12/2018
4	RNA (Ribonucleic Acid)IBA 01/2023 - 01/2021
4	Transcription Factors (Transcription Factor)IBA 01/2021 - 06/2009
4	Phenylephrine (Neo-Synephrine)FDA LinkGeneric 10/2020 - 11/2007
3	Matrix Metalloproteinases (MMPs)IBA 03/2024 - 01/2020
3	Anti-Arrhythmia AgentsIBA 02/2024 - 01/2017
3	Contrast MediaIBA 12/2023 - 02/2018
3	Dobutamine FDA LinkGeneric 10/2023 - 01/2023
3	Protein Isoforms (Isoforms)IBA 09/2023 - 05/2011
3	Messenger RNA (mRNA)IBA 03/2023 - 10/2010
3	Prealbumin (Transthyretin)IBA 01/2023 - 01/2018
3	salicylhydroxamic acid (SHAM)IBA 03/2022 - 01/2008
3	OligonucleotidesIBA 01/2022 - 01/2021
3	Ion Channels (Ion Channel)IBA 10/2021 - 09/2021
3	N-propionylprocainamideIBA 10/2021 - 02/2016
3	5-nitro-2-(3-phenylpropylamino)benzoic acidIBA 10/2021 - 02/2016
3	DysbindinIBA 10/2020 - 11/2013
3	AdipokinesIBA 01/2018 - 07/2011
3	CalciumIBA 01/2016 - 04/2002
3	Protein Kinases (Protein Kinase)IBA 01/2016 - 07/2014
3	Phosphoric Monoester Hydrolases (Phosphatases)IBA 08/2015 - 04/2002
3	Atrial Natriuretic Factor (ANF)IBA 10/2010 - 12/2007
2	trans-crotonin (CTN)IBA 01/2024 - 12/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2024 - 04/2022
2	Adenosine (Adenocard)FDA LinkGeneric 10/2023 - 01/2023
2	Peptides (Polypeptides)IBA 06/2023 - 01/2020
2	EpitopesIBA 06/2023 - 12/2018

Therapy/Procedure

33	Therapeutics 04/2024 - 10/2002
19	Transcatheter Aortic Valve Replacement 04/2024 - 09/2015
10	Heart Transplantation (Grafting, Heart) 03/2023 - 04/2014
7	Drug Therapy (Chemotherapy) 04/2023 - 09/2014
6	Percutaneous Coronary Intervention 10/2023 - 10/2002
5	Stents 01/2023 - 01/2016
3	Extracorporeal Membrane Oxygenation 10/2023 - 12/2020
3	Length of Stay 10/2023 - 12/2021
3	Resuscitation 07/2022 - 07/2010
3	Ligation 07/2014 - 01/2008